Arisa Akashi Sin

We advised Virgin Group Acquisition Corp. II, a SPAC, on its IPO and NYSE listing

We advised European Biotech Acquisition, a SPAC, on its IPO and Nasdaq listing

We advised the underwriters on the SPAC IPO and Nasdaq listing

We are advising a SPAC on its merger with 23andMe

We advised the underwriters in connection with the SEC-registered equity offering

We advised the underwriters on the SPAC IPO and NYSE listing

Davis Polk advised LendingTree, Inc. in connection with the $872 million secondary offering of 2,955,984 shares of its common stock by Ventures Holdco II, LLC, which is a wholly owned…

Davis Polk advised VG Acquisition Corp. on its $480 million initial public offering of 48,000,000 units. Each unit had an initial offering price of $10 and consists of one Class A ordinary…

Davis Polk advised Gilead Sciences, Inc. in connection with an SEC-registered offering of $7.25 billion aggregate principal amount of senior notes, consisting of (i) $500 million aggregate…

Davis Polk advised the underwriter in connection with the initial public offering of 30,000,000 units of Broadstone Acquisition Corp., for aggregate proceeds of $300 million. Each unit…